Events2Join

Are All Alpha|Blockers Created the Same?


Alpha blockers: are all created equal? - PubMed

Drug therapy with alpha blockers has become the standard treatment for patients with benign prostatic hyperplasia. Medical treatment is often preferred by ...

Are All Alpha-Blockers Created the Same? - European Urology

A meta-analysis on the efficacy and tolerability of alpha 1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign ...

Are all alpha-blockers created the same? - PubMed

Are all alpha-blockers created the same? Eur Urol. 2006 Mar;49(3):420-2. doi: 10.1016/j.eururo.2005.12.032. Epub 2006 Jan 6.

Are All Alpha-Blockers Created the Same? - European Urology

In the next decade, the number of men who will consult for lower urinary tract symptoms (LUTS), often in connection with benign prostatic hyperpla-.

Surprising clinical differences among alpha blockers demonstrated ...

Tamsulosin and terazosin had lower-than-expected relative incidence for the same events. ... Alpha blockers: are all created equal? Urology, 56 (5 Suppl 1) (2000) ...

Alpha blockers - Mayo Clinic

Alpha blockers are either short-acting or long-acting medicines. Short-acting medicines work quickly, but their effects last only a few hours. Long-acting ...

Alpha-blockers: Types, Uses and Side Effects - Cleveland Clinic

Non-selective alpha-blockers are meant for short-term use. For conditions like high blood pressure or benign prostate hyperplasia, it's common to take an alpha- ...

Alpha blocker - Wikipedia

Alpha blockers, also known as α-blockers or α-adrenoreceptor antagonists, are a class of pharmacological agents that act as antagonists on α-adrenergic ...

Alpha Blockers vs. 5-Alpha Reductase Inhibitors - Rezum

Alpha blockers and 5-alpha reductase inhibitors are both common BPH medications, but they work differently.

Alpha-1 blocker - Wikipedia

Over the last 40 years, a variety of drugs have been developed from non-selective alpha-1 receptor antagonists to selective alpha-1 antagonists and alpha-1 ...

Treatment Patterns in Alpha-Blocker Therapy for Benign Prostatic ...

Two thirds of the men discontinued alpha-blocker in the 12-month period, among which restarts or switches were statistically different (p = .036) ...

Alpha-blockers: Uses, Prescription, and Side-effects - Patient.info

For people with symptoms caused by prostate gland enlargement, alpha-blockers are also usually taken long-term. Your doctor will usually review your symptoms 4- ...

Alpha-blockers - Blood Pressure UK

Alpha-blockers are a type of medicine that can be used to treat high blood pressure. They work by allowing the blood vessels to relax and widen.

Your benign prostatic hyperplasia medication: When to consider a ...

The alpha-1 blockers are classed into two groups. The selective agents, alfuzosin (Uroxatral), silodosin (Rapaflo), and tamsulosin (Flomax, ...

Are All Alpha-Blockers Created the Same? | CoLab

In the next decade, the number of men who will consult for lower urinary tract symptoms (LUTS), often in connection with benign prostatic ...

Flomax alternatives: Alpha-blockers and treatment options

Other alpha-blockers work in much the same way as Flomax. Doxazosin may cost ... A prostatectomy is a procedure in which the surgeon removes all or a portion of ...

Prescription pattern of alpha-blockers for management of lower ...

The use of α1-adrenergic blockers is based on targeting both bladder α1d-adrenergic receptors and prostate α1a-adrenergic receptors, which are ...

So You're Gonna... Start an Alpha-blocker - Talking Urology

CLAUS: Well there's a couple of common mistakes that are being made. The first one is those urologists' switch alpha-blockers for efficacy reason. They argue ...

Cardiovascular Outcomes of α-Blockers vs 5-α Reductase Inhibitors ...

... all Medicare enrollees from 2013 to 2017 (eFigures 1-3 in Supplement ... same variables as the PS model). Stabilized IPCWs were ...

Medical management of benign prostatic hyperplasia

Alpha-blockers are a class of drugs first introduced in the late 1980s and early 1990s. They work by antagonizing alpha-1 receptors in the ...